PLK1 and colorectal carcinoma: To investigate the crucial role of CDC7 as a downstream effector of PLK1, we depleted CDC7 with siRNA and found that CDC7 depletion dramatically inhibited colony formation in CRC cells treated with oxaliplatin (Figure 6A).